1 July 2022 false Taxfiler 2024.1 10834912business:PrivateLimitedCompanyLtd2022-07-012023-06-30 108349122022-06-30 108349122022-07-012023-06-30 10834912business:AuditExemptWithAccountantsReport2022-07-012023-06-30 10834912business:FilletedAccounts2022-07-012023-06-30 108349122023-06-30 10834912business:Director12022-07-012023-06-30 10834912business:Director22022-07-012023-06-30 10834912business:Director42022-07-012023-06-30 10834912business:RegisteredOffice2022-07-012023-06-30 108349122022-06-30 10834912core:WithinOneYear2023-06-30 10834912core:WithinOneYear2022-06-30 10834912core:AfterOneYear2023-06-30 10834912core:AfterOneYear2022-06-30 10834912core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 10834912core:ShareCapitalcore:PreviouslyStatedAmount2022-06-30 10834912core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 10834912core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-06-30 10834912core:PreviouslyStatedAmount2023-06-30 10834912core:PreviouslyStatedAmount2022-06-30 10834912business:SmallEntities2022-07-012023-06-30 10834912countries:EnglandWales2022-07-012023-06-30 10834912core:FurnitureFittings2022-07-012023-06-30 10834912core:MotorVehicles2022-06-30 10834912core:FurnitureFittings2022-06-30 10834912core:MotorVehicles2023-06-30 10834912core:FurnitureFittings2023-06-30 10834912core:MotorVehicles2022-07-012023-06-30 10834912business:OrdinaryShareClass12022-07-012023-06-30 10834912business:OrdinaryShareClass12021-07-012022-06-30 10834912business:OrdinaryShareClass22022-07-012023-06-30 10834912business:OrdinaryShareClass22021-07-012022-06-30 10834912business:OrdinaryShareClass32022-07-012023-06-30 10834912business:OrdinaryShareClass32021-07-012022-06-30 10834912business:AllOrdinaryShares2022-07-012023-06-30 10834912business:AllOrdinaryShares2021-07-012022-06-30 108349122021-07-012022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 10834912 (England and Wales)
ZS Pharma Limited Filleted accounts for the year ended 30 June 2023
ZS Pharma Limited Filleted accounts Contents
Page
- 2 -
ZS Pharma Limited Company Information for the year ended 30 June 2023
Directors
Mr Sarfraz Patel Mr Zahid Patel Mrs Nawal Haddouch
Company Number
10834912 (England and Wales)
Registered Office
109a Barkby Road Leicester LE4 9LG
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
ZS Pharma Limited Statement of financial position as at 30 June 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
67,207 
90,367 
Current assets
Inventories
26,372 
54,273 
Debtors
224,567 
184,892 
Cash at bank and in hand
150,451 
123,288 
401,390 
362,453 
Creditors: amounts falling due within one year
(227,213)
(476,705)
Net current assets/(liabilities)
174,177 
(114,252)
Total assets less current liabilities
241,384 
(23,885)
Creditors: amounts falling due after more than one year
(160,583)
- 
Net assets/(liabilities)
80,801 
(23,885)
Capital and reserves
Called up share capital
97 
97 
Profit and loss account
80,704 
(23,982)
Shareholders' funds
80,801 
(23,885)
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 1 April 2024 and were signed on its behalf by
Mr Zahid Patel Director Company Registration No. 10834912
- 4 -
ZS Pharma Limited Notes to the Accounts for the year ended 30 June 2023
1
Statutory information
ZS Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 10834912. The registered office is 109a Barkby Road, Leicester, LE4 9LG.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% straight line
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
ZS Pharma Limited Notes to the Accounts for the year ended 30 June 2023
4
Tangible fixed assets
Motor vehicles 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 July 2022
17,440 
102,153 
119,593 
At 30 June 2023
17,440 
102,153 
119,593 
Depreciation
At 1 July 2022
4,360 
24,866 
29,226 
Charge for the year
4,360 
18,800 
23,160 
At 30 June 2023
8,720 
43,666 
52,386 
Net book value
At 30 June 2023
8,720 
58,487 
67,207 
At 30 June 2022
13,080 
77,287 
90,367 
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
VAT
69,196 
67,660 
Trade debtors
149,889 
117,232 
Other debtors
5,482 
- 
224,567 
184,892 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Bank loans and overdrafts
62,516 
- 
Trade creditors
123,889 
329,042 
Taxes and social security
8,161 
1,742 
Other creditors
17,173 
129,246 
Loans from directors
14,000 
14,000 
Accruals
1,474 
2,675 
227,213 
476,705 
7
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Bank loans
160,583 
- 
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
4,200 A Ordinary shares of £0.01 each
42 
42 
4,000 B Ordinary shares of £0.01 each
40 
40 
1,500 C Ordinary shares of £0.01 each
15 
15 
97 
97 
- 6 -
ZS Pharma Limited Notes to the Accounts for the year ended 30 June 2023
9
Average number of employees
During the year the average number of employees was 8 (2022: 8).
- 7 -